Category: Pharma Industry

Five Major Drug Makers Oppose Health Center’s Legal Challenge to 340B Patient Definition

August 8, 2023 Views

AbbVie, BMS, Lilly, and Merck jointly asked a federal district court to dismiss a health center’s challenge to the 340B patient definition. Drug maker Janssen asked the same separately.

Drug makers AbbVie, Bristol Myers Squibb, Janssen, Lilly, and Merck asked a federal district court in South Carolina on Friday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Charge Average 500% of Top 20 Drug Costs, Says PhRMA-Funded Analysis

August 8, 2023 Views

A Moran Company study, funded by PhRMA, found 340B hospitals charge an average of 500% above acquisition costs for 20 high-cost drugs.

Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Loosens 340B Contract Pharmacy Restrictions in Two States as Louisiana Law Takes Effect

August 3, 2023 Views

Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.

Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana’s New 340B Contract Pharmacy Law Goes Into Effect Today; PhRMA Sues and Teva Suspends its Restrictions in the State

August 1, 2023 Views

Brand drug trade group PhRMA is suing Louisiana over its law protecting 340B contract pharmacy arrangements.

Today is the first day of Louisiana’s new law protecting 340B program contract pharmacy arrangements and there have already been [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

July 27, 2023 Views

Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.

The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

July 25, 2023 Views

340B Working Table 340B lobbying disclosure form

Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

…

Generic Drugmaker Amring Providing Refunds for 340B Overcharges

July 20, 2023 Views

Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

July 20, 2023 Views

Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.

Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

July 13, 2023 Views

Drug manufacturer VistaPharm says requests for refunds for 340B overcharges must be received before Aug. 31. No manufacturer is believed to have set such a deadline before, and it's unclear if VistaPharm is the first to say refunds are available upon request.

Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UPDATED: Astellas and AstraZeneca Make 340B Contract Pharmacy Moves

July 3, 2023 Views

Astellas is the third drugmaker to loosen or end its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.

Drug manufacturers Astellas and AstraZeneca announced today separate contract pharmacy policies for 340B providers that will go into effect in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Five Major Drug Makers Oppose Health Center’s Legal Challenge to 340B Patient Definition

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Hospitals Charge Average 500% of Top 20 Drug Costs, Says PhRMA-Funded Analysis

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Merck Loosens 340B Contract Pharmacy Restrictions in Two States as Louisiana Law Takes Effect

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Louisiana’s New 340B Contract Pharmacy Law Goes Into Effect Today; PhRMA Sues and Teva Suspends its Restrictions in the State

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

Generic Drugmaker Amring Providing Refunds for 340B Overcharges

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

Please Login or Become a Paid Subscriber to View this Content

If you are already a

In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

UPDATED: Astellas and AstraZeneca Make 340B Contract Pharmacy Moves

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live